| Extrahepatic manifestations of hepatitis C: a meta-analysis of prevalence, quality of life, and economic burden Z Younossi, H Park, L Henry, A Adeyemi, M Stepanova Gastroenterology 150 (7), 1599-1608, 2016 | 454 | 2016 |
| Cost‐effectiveness of all‐oral ledipasvir/sofosbuvir regimens in patients with chronic hepatitis C virus genotype 1 infection ZM Younossi, H Park, S Saab, A Ahmed, D Dieterich, SC Gordon Alimentary pharmacology & therapeutics 41 (6), 544-563, 2015 | 157 | 2015 |
| Efficacy and safety of dipeptidyl peptidase-4 inhibitors in type 2 diabetes: meta-analysis H Park, C Park, Y Kim, KL Rascati Annals of Pharmacotherapy 46 (11), 1453-1469, 2012 | 145 | 2012 |
| A meta‐analytic assessment of the risk of chronic kidney disease in patients with chronic hepatitis C virus infection H Park, A Adeyemi, L Henry, M Stepanova, Z Younossi Journal of viral hepatitis 22 (11), 897-905, 2015 | 110 | 2015 |
| Chronic hepatitis C virus (HCV) increases the risk of chronic kidney disease (CKD) while effective HCV treatment decreases the incidence of CKD H Park, C Chen, W Wang, L Henry, RL Cook, DR Nelson Hepatology 67 (2), 492-504, 2018 | 97 | 2018 |
| Effectiveness and safety of apixaban versus rivaroxaban for prevention of recurrent venous thromboembolism and adverse bleeding events in patients with venous thromboembolism … GK Dawwas, J Brown, E Dietrich, H Park The Lancet Haematology 6 (1), e20-e28, 2019 | 90 | 2019 |
| Cost‐effectiveness analysis of sofosbuvir plus peginterferon/ribavirin in the treatment of chronic hepatitis C virus genotype 1 infection S Saab, SC Gordon, H Park, M Sulkowski, A Ahmed, Z Younossi Alimentary pharmacology & therapeutics 40 (6), 657-675, 2014 | 90 | 2014 |
| US national trends in bariatric surgery: a decade of study AA Alalwan, J Friedman, H Park, R Segal, BA Brumback, AG Hartzema Surgery 170 (1), 13-17, 2021 | 85 | 2021 |
| Immune checkpoint inhibitors and immune-related adverse events in patients with advanced melanoma: a systematic review and network meta-analysis CY Chang, H Park, DC Malone, CY Wang, DL Wilson, YM Yeh, ... JAMA network open 3 (3), e201611-e201611, 2020 | 85 | 2020 |
| Nonalcoholic fatty liver disease increases risk of incident advanced chronic kidney disease: a propensity‐matched cohort study H Park, GK Dawwas, X Liu, MH Nguyen Journal of internal medicine 286 (6), 711-722, 2019 | 76 | 2019 |
| Cardiovascular outcomes of sodium glucose cotransporter‐2 inhibitors in patients with type 2 diabetes GK Dawwas, SM Smith, H Park Diabetes, Obesity and Metabolism 21 (1), 28-36, 2019 | 72 | 2019 |
| Real-world outcomes of ledipasvir/sofosbuvir in treatment-naive patients with hepatitis C ZM Younossi, H Park, SC Gordon, JR Ferguson, A Ahmed, D Dieterich, ... Am J Manag Care 22 (6), 205-11, 2016 | 67 | 2016 |
| Impact of all‐oral direct‐acting antivirals on clinical and economic outcomes in patients with chronic hepatitis C in the United States H Park, W Wang, L Henry, DR Nelson Hepatology 69 (3), 1032-1045, 2019 | 61 | 2019 |
| Adherence and persistence to prescribed medication therapy among Medicare part D beneficiaries on dialysis: comparisons of benefit type and benefit phase H Park, KL Rascati, KA Lawson, JC Barner, KM Richards, DC Malone Journal of Managed Care Pharmacy 20 (8), 862-876, 2014 | 60 | 2014 |
| Evaluation of health care costs and utilization patterns for patients with gout H Park, KL Rascati, K Prasla, T McBayne Clinical therapeutics 34 (3), 640-652, 2012 | 48 | 2012 |
| Assessment of cost of innovation versus the value of health gains associated with treatment of chronic hepatitis C in the United States: the quality-adjusted cost of care ZM Younossi, H Park, D Dieterich, S Saab, A Ahmed, SC Gordon Medicine 95 (41), e5048, 2016 | 45 | 2016 |
| Direct medical costs and utilization of health care services to treat pneumonia in the United States: an analysis of the 2007–2011 Medical Expenditure Panel Survey H Park, AO Adeyemi, KL Rascati Clinical therapeutics 37 (7), 1466-1476. e1, 2015 | 39 | 2015 |
| Rising inpatient encounters and economic burden for patients with nonalcoholic fatty liver disease in the USA AL Nguyen, H Park, P Nguyen, E Sheen, YA Kim, MH Nguyen Digestive diseases and sciences 64, 698-707, 2019 | 34 | 2019 |
| Trends in anemia care in non-dialysis-dependent chronic kidney disease (CKD) patients in the United States (2006–2015) H Park, X Liu, L Henry, J Harman, EA Ross BMC nephrology 19, 1-10, 2018 | 33 | 2018 |
| Cost-effectiveness of expanded newborn screening in Texas SK Tiwana, KL Rascati, H Park Value in Health 15 (5), 613-621, 2012 | 33 | 2012 |
